PRESS-RELEASE ·Filed May 8, 2026
Press release · Activist
Actionable Insight • Neutral
No trading action warranted. Monitor upcoming Phase 3 data for cadisegliatin as primary catalyst.
VTVT drugs
VTVT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60Entry
$30.46
T+0 close · May 8, 2026 · via day close
Latest settled
+12.90%
T+60 · $34.39
Vs SPY
+8.51%
α at T+60
Horizons
All settled
through T+60
- T+0 · May 11 $30.46entry
- T+1 · 6mo ago +5.42%α +5.55% · $32.11
- T+5 · 6mo ago +16.51%α +16.60% · $35.49
- T+20 · 5mo ago +4.30%α +4.61% · $31.77
- T+60 · 3mo ago +12.90%α +8.51% · $34.39
Price Chart
Loading chart...
How similar events traded
Executive Summary
vTv Therapeutics granted 39,500 stock options to two non-executive employees as inducement awards. This is a routine compensation event with no material impact on the company's operations or financials.
Key Facts
- 39,500 stock options granted to two non-executive employees
- Weighted average exercise price of $32.00 per share
- Options vest over 4 years with 25% cliff at one year
- Options have a 10-year term
Financial Impact
Minimal; options represent less than 0.5% of outstanding shares (assuming ~10M shares outstanding)
dilution
Risk Factors
- Dilution from options is negligible
- No change to clinical or regulatory outlook
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291335 |
Track record
9 reports on VTVT
Filters
- Nov 16, 2026today SC 13D/A Neutral 3/10 Entry $17.69 Now $17.69 +0.00% settles Dec 16
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $19.69 Now $17.69 −10.16% settles Dec 14
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $21.03 Now $17.69 −15.88% settles Dec 7
- Oct 8, 20265w ago SC 13G/A Neutral 3/10 Entry $31.18 to $21.03 Now $17.69 −43.26% ▼ −32.55% −26.99% vs SPY
- Jun 10, 202622w ago DEFA14A Neutral 3/10 Entry $31.59 to $33.44 Now $17.69 −44.00% ▲ +5.86% +3.97% vs SPY
- May 8, 202627w ago Press Release Neutral 2/10 Viewing Entry $30.46 to $31.77 Now $17.69 −41.92% ▲ +4.30% +4.61% vs SPY
- Mar 10, 202635w ago Press Release Mixed 6/10 Entry $35.10 to $37.30 Now $17.69 −49.60% ▲ +6.27% +5.74% vs SPY
- Feb 26, 202637w ago 8-K Neutral 4/10 Entry $39.32 to $37.80 Now $17.69 −55.01% ▼ −3.87% +2.54% vs SPY
Showing 9 of 9
US Market Status
Market Closed · Opens in 6h 21m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers